Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2881 AL 2895

Systematic review of gene expression studies in people with Lewy body dementia

Chowdhury A, Rajkumar AP.

Acta Neuropsychiatr. 2020 Dec;32(6):281-292. doi: 10.1017/neu.2020.13. Epub 2020 Mar 17.

Novel biomarkers for the evaluation of aging-induced proteinopathies

Yanar K, Atayik MC, Simsek B, Çakatay U.

Biogerontology. 2020 Oct;21(5):531-548. doi: 10.1007/s10522-020-09878-8. Epub 2020 Apr 9.

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

Irwin DJ, Fedler J, Coffey CS, Caspell-Garcia C, Kang JH, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, Galasko DR, Siderowf A, Marek K, Trojanowski JQ, Shaw LM; Parkinson's Progression Marker Initiative.

Ann Neurol. 2020 Sep;88(3):574-587. doi: 10.1002/ana.25811. Epub 2020 Jul 2.

Application of Contemporary Neuroproteomic Techniques in Unravelling Neurological Disorders

Khurana M, Rahman SO, Najmi AK, Pottoo FH, Akhtar MS.

Curr Protein Pept Sci. 2020;21(12):1146-1163. doi: 10.2174/1389203721666201104130135.

Extracellular vesicles - propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases

Vassileff N, Cheng L, Hill AF.

J Cell Sci. 2020 Dec 11;133(23):jcs243139. doi: 10.1242/jcs.243139.

Frontal variant of Alzheimer's disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review

Li CH, Fan SP, Chen TF, Chiu MJ, Yen RF, Lin CH.

Brain Behav. 2020 Mar;10(3):e01548. doi: 10.1002/brb3.1548. Epub 2020 Jan 27.

3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases

Bandookwala M, Sengupta P.

Int J Neurosci. 2020 Oct;130(10):1047-1062. doi: 10.1080/00207454.2020.1713776. Epub 2020 Jan 21.

Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis

Puranik N, Yadav D, Yadav SK, Chavda VK, Jin JO.

Curr Protein Pept Sci. 2020;21(12):1174-1183. doi: 10.2174/1389203721666200511094222.

Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer's Disease Dementia

Bottero V, Potashkin JA.

Int J Mol Sci. 2019 Oct 30;20(21):5403. doi: 10.3390/ijms20215403.

Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases

Cilento EM, Jin L, Stewart T, Shi M, Sheng L, Zhang J.

J Neurochem. 2019 Nov;151(4):397-416. doi: 10.1111/jnc.14635. Epub 2019 Jan 31.

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders

Yilmaz A, Fuchs D, Price RW, Spudich S, Blennow K, Zetterberg H, Gisslén M.

Curr HIV/AIDS Rep. 2019 Feb;16(1):76-81. doi: 10.1007/s11904-019-00420-1.

Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease

Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA.

Int J Mol Sci. 2019 Feb 8;20(3):719. doi: 10.3390/ijms20030719.

Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease

Nakajima A, Ohizumi Y.

Int J Mol Sci. 2019 Jul 10;20(14):3380. doi: 10.3390/ijms20143380.

Standardized measurement of circulating vitamin D [25(OH)D] and its putative role as a serum biomarker in Alzheimer's disease and Parkinson's disease

Bivona G, Lo Sasso B, Iacolino G, Gambino CM, Scazzone C, Agnello L, Ciaccio M.

Clin Chim Acta. 2019 Oct;497:82-87. doi: 10.1016/j.cca.2019.07.022. Epub 2019 Jul 19.

Comparison of Methods for Differential Co-expression Analysis for Disease Biomarker Prediction

Kakati T, Bhattacharyya DK, Barah P, Kalita JK.

Comput Biol Med. 2019 Oct;113:103380. doi: 10.1016/j.compbiomed.2019.103380. Epub 2019 Aug 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias